Improved Ultrasound Attenuation Measurement Method for the Non-invasive Evaluation of Hepatic Steatosis Using FibroScan.

Controlled attenuation parameter (CAP) is a measurement of ultrasound attenuation used to assess liver steatosis non-invasively. However, the standard method has some limitations. This study assessed the performance of a new CAP method by ex vivo and in vivo assessments. The major difference with the new method is that it uses ultrasound data continuously acquired during the imaging phase of the FibroScan examination. Seven reference tissue-mimicking phantoms were used to test the performance. In vivo performance was assessed in two cohorts (in total 195 patients) of patients using magnetic resonance imaging proton density fat fraction (MRI-PDFF) as a reference. The precision of CAP was improved by more than 50% on tissue-mimicking phantoms and 22%-41% in the in vivo cohort studies. The agreement between both methods was excellent, and the correlation between CAP and MRI-PDFF improved in both studies (0.71 to 0.74; 0.70 to 0.76). Using MRI-PDFF as a reference, the diagnostic performance of the new method was at least equal or superior (area under the receiver operating curve 0.889-0.900, 0.835-0.873). This study suggests that the new continuous CAP method can significantly improve the precision of CAP measurements ex vivo and in vivo.

Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic Accuracy.

To assess liver steatosis, the controlled attenuation parameter (CAP; giving an estimate of ultrasound attenuation ∼3.5 MHz) is available with the M probe of the FibroScan. We report on the adaptation of the CAP for the FibroScan XL probe (center frequency 2.5 MHz) without modifying the range of values (100-400 dB/m). CAP validation was successfully performed on Field II simulations and on tissue-mimicking phantoms. In vivo performance was assessed in a cohort of 59 patients spanning the range of steatosis. In vivo reproducibility was good and similar with both probes. The area under receiver operative characteristic curve was equal to 0.83/0.84 and 0.92/0.91 for the M/XL probes to detect >2% and >16% liver fat, respectively, as assessed by magnetic resonance imaging. Patients can now be assessed simultaneously for steatosis and fibrosis using the FibroScan, regardless of their morphology.

Maximum likelihood estimation of shear wave speed in transient elastography.

Ultrasonic transient elastography (TE), enables to assess, under active mechanical constraints, the elasticity of the liver, which correlates with hepatic fibrosis stages. This technique is routinely used in clinical practice to assess noninvasively liver stiffness. The Fibroscan system used in this work generates a shear wave via an impulse stress applied on the surface of the skin and records a temporal series of radio-frequency (RF) lines using a single-element ultrasound probe. A shear wave propagation map (SWPM) is generated as a 2-D map of the displacements along depth and time, derived from the correlations of the sequential 1-D RF lines, assuming that the direction of propagation (DOP) of the shear wave coincides with the ultrasound beam axis (UBA). Under the assumption of pure elastic tissue, elasticity is proportional to the shear wave speed. This paper introduces a novel approach to the processing of the SWPM, deriving the maximum likelihood estimate of the shear wave speed when comparing the observed displacements and the estimates provided by the Green's functions. A simple parametric model is used to interface Green's theoretical values of noisy measures provided by the SWPM, taking into account depth-varying attenuation and time-delay. The proposed method was evaluated on numerical simulations using a finite element method simulator and on physical phantoms. Evaluation on this test database reported very high agreements of shear wave speed measures when DOP and UBA coincide.

Evaluation of in vivo liver tissue characterization with spectral RF analysis versus elasticity.

Ultrasonic elastography, via vibration-controlled transient elastography (VCTE), enables to assess, under active mechanical constraints, the elasticity of the liver, correlating with fibrosis stages. On the other hand, the same VCTE probe can also be used in passive mode, acquiring RF lines at different locations in the liver. This paper presents a thorough evaluation of passive-mode RF spectral parameters (integrated backscatter coefficient, power spectral index, effective scattering size and spectral variance), for tissue characterization on a large cohort of volunteers with various ranges of elasticity measures. Results showed that capabilities to discriminate between liver and subcutaneous fat tissues were highly variable among spectral parameters. Furthermore, it appears that no in vivo discrimination of liver elasticity/fibrosis stage can be performed with passive RF spectral analysis, at 3.5MHz.

Measurement of the skin-liver capsule distance on ultrasound RF data for 1D transient elastography.

Vibration-controlled transient elastography (VCTETM) technique is routinely used in clinical practice to assess non-invasively the liver stiffness which is correlated to hepatic fibrosis. Adequate use of the VCTETM probe requires the knowledge of the distance between the skin and the liver parenchyma. This paper compares two methods to estimate this distance using spatial variations of the spectral content of ultrasound radiofrequency (RF) lines, obtained from a probe consisting of a single element ultrasound transducer placed in front of the liver right lobe. Results on a database of 188 patients, including normal-weight and obese persons, show that the spectral variance can accurately discriminate the subcutaneous fat from the liver tissue. The proposed algorithm works in real-time and is suitable for VCTETM scanning protocol setup.